文献速递肝病消化道肿瘤与早癌

年轻成人代谢功能障碍相关脂肪性肝病增加早发性癌症风险:一项区分23种部位特异性癌症的全国性队列研究

Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease Have an Increased Risk of Early-Onset Cancer: A Nationwide Cohort Study Differentiating the Risk of 23 Site-Specific Cancers.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-05-08

该研究基于韩国全国健康筛查数据库,纳入2013至2014年2877245名20-39岁年轻成人,随访至2022年12月31日。结果显示,与非SLD组相比,MASLD组(HR 1.19)、MetALD组(HR 1.12)和ALD组(HR 1.21)全癌风险均升高,且MASLD组中心代谢危险因素数量越多全癌风险越高。

要点

  • MASLD、MetALD和ALD组全癌风险均高于非SLD组,HR分别为1.19、1.12和1.21。
  • MASLD组中心代谢危险因素数量增加与全癌风险升高呈趋势。
  • 饮酒对总体癌症风险影响 modest,但对特定癌种影响各异。

核心结论

  • 患有MASLD、MetALD或ALD的年轻成人发生早发性癌症的风险增加。

研究设计与样本

  • 基于韩国全国健康筛查数据库的全国性队列研究,纳入2013至2014年2877245名20-39岁年轻成人,随访至2022年12月31日。
  • 根据脂肪肝指数≥30定义肝脂肪变,将个体分为非SLD、MASLD、MetALD和ALD组。
  • 采用Cox比例风险回归模型估计风险比(HR)。

主要发现

  • 随访22,819,681人年期间,发生46,729例 incident cancer。
  • 与非SLD组相比,MASLD组全癌风险升高(HR 1.19;95%CI 1.16-1.22;P<.001),MetALD组升高(HR 1.12;95%CI 1.07-1.18;P<.001),ALD组升高(HR 1.21;95%CI 1.12-1.31;P<.001)。
  • 多数肥胖相关癌症在MASLD或MetALD个体中风险增加。
  • MASLD组中,随着中心代谢危险因素数量增加,全癌风险呈增加趋势。
  • 饮酒对总体癌症风险影响 modest,但对特定癌症类型影响各异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We investigated the association between subtypes of steatotic liver disease (SLD) and 23 site-specific cancers in a nationwide cohort of young Korean adults. METHODS: From a nationwide health screening database in Korea, 2,877,245 young adults 20-39 years of age between 2013 and 2014 were included and followed up until December 31, 2022. Individuals were categorized into non-SLD, metabolic dysfunction-associated steatotic liver disease (MASLD), MASLD with increased alcohol intake (MetALD), and alcohol-associated liver disease (ALD) groups. Hepatic steatosis was defined as a fatty liver index ≥30. The primary outcome was all cancers, while secondary outcomes included 23 site-specific cancers. Cox proportional hazards regression models were used to estimate hazard ratios (HRs). RESULTS: During 22,819,681 person-years of follow-up, 46,729 incident cancer cases developed. The MASLD (HR, 1.19; 95% confidence interval [CI], 1.16-1.22; P < .001) MetALD (HR, 1.12; 95% CI, 1.07-1.18; P < .001), and ALD (HR, 1.21; 95% CI, 1.12-1.31; P < .001) groups had a higher risk of all cancers compared with the non-SLD group. Most obesity-related cancers showed increased risk in individuals with either MASLD or MetALD. There was an increasing trend in all-cancer risk with increasing number of cardiometabolic risk factors among MASLD. Alcohol consumption had a modest effect on overall cancer risk, with varying effects on specific cancer types. CONCLUSIONS: Young adults with MASLD, MetALD, or ALD are at increased risk of developing early-onset cancer.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Moon JH, Jeong S, Jang H, et al. Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease Have an Increased Risk of Early-Onset Cancer: A Nationwide Cohort Study Differentiating the Risk of 23 Site-Specific Cancers. Clin Gastroenterol Hepatol. 2025. PMID: 40348107. doi:10.1016/j.cgh.2025.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。